Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations-Reference-Cited by-同舟云学术

Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations

Published:2019 Issue: Volume:26 Page:193-196
ISSN:2213-0071
Container-title:Respiratory Medicine Case Reports
language:en
Short-container-title:Respiratory Medicine Case Reports

Author:

Aoyama Junichi,Hayashi Hiroki,Yajima Chika,Takoi Hiroyuki,Tanaka Toru,Kashiwada Takeru,Kokuho Nariaki,Terasaki Yasuhiro,Nishikawa Ayumi,Gono Takahisa,Kuwana Masataka^ORCID,Saito Yoshinobu,Abe Shinji,Seike Masahiro,Gemma Akihiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference19 articles.

1. Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies;Sato;PLoS One,2016

2. Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody;Nagata;Ann. Jpn. Respir. Soc.,2011

3. Anti-MDA5(melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia;Nakashima;Jpn. J. Clin. Immunol.,2013

4. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease;Sato;Arthritis Rheum.,2009

5. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study;Fiorentino;J. Am. Acad. Dermatol.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis in a patient with silicone breast implants;Journal of Cutaneous Immunology and Allergy;2024-05-28

2. High-Dose Tigecycline for the Treatment of Progressive Pneumonia Caused by Chlamydia psittaci: Case Series and Literature Review;Infection and Drug Resistance;2023-01

3. COVID-19 as a putative trigger of anti-MDA5-associated dermatomyositis with acute respiratory distress syndrome (ARDS) requiring lung transplantation, a case report;BMC Rheumatology;2022-07-13

4. Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review;Rheumatology International;2022-06-04

5. Pharmacologic Treatment of Anti-MDA5 Rapidly Progressive Interstitial Lung Disease;Current Treatment Options in Rheumatology;2021-09-28